ftInvstr

VAISHALI · Healthcare ₹6.98 +0.58% Mkt Cap ₹91 Cr

VAISHALI

Healthcare Drug Manufacturers - Specialty & Generic

★ Watchlist ⧉ Add to bucket

₹6.98

+0.58% today · 30d -12.53%

as of 2026-11-09

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for VAISHALI. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2025-12-31

REVENUE

₹25 Cr

-11.69% YoY

NET PROFIT

₹1 Cr

-8.64% YoY

OPM

9.6%

+1.2pp YoY

EPS

₹0.1

Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-20.2% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.

◇ Sector Position

PEERPEROCE %

VAISHALI111.34—

SUNPHARMA37.7921.44

DIVISLAB93.121.56

ZYDUSLIFE28.424.22

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance UNDERPERFORMER 5

Valuation STRETCHED 5

Growth STEADY 63

Profitability DECENT 55

Technicals WEAK 40

Risk LOW 90

Key Stats

P/B

1.32

52W HIGH

₹11.15

OFF HIGH

-37.4%

DIV YIELD

0.0%

MKT CAP

₹91 Cr

◉ Active Signals

MACDNeutral0.0382

RSI(14)Neutral41.9

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold VAISHALI and at what entry.